Logo of jester cap with thought bubble with words 'Fool Transcripts' below it

Image source: The Motley Fool.

CME Group (CME 0.60%)
Q1 2018 Earnings Conference Call
April 26, 2018 8:30 a.m. ET

Contents:

  • Prepared Remarks
  • Questions and Answers
  • Call Participants

Prepared Remarks:

Operator

Please stand by. Good day, and welcome to the CME Group first-quarter 2018 earnings call. At this time, I'd like to turn the conference over to Mr. John Peschier.

Please go ahead, sir.

John Peschier -- Managing Director, Investor Relations

Good morning, and thank you all for joining us today. I'm going to start with the safe harbor language, and then I'll turn it over to Terry for brief remarks, then we'll open it up for your questions. Other members of our management team will also participate in the Q&A. Statements made on this call and in the slides on our website that are not historical facts are forward-looking statements.

These statements are not guarantees of future performance. They involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any statements. More detailed information about factors that may affect our performance can be found in our filings with the SEC, which are on our website.

10 stocks we like better than CME Group
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and CME Group wasn't one of them! That's right -- they think these 10 stocks are even better buys.

Click here to learn about these picks!

*Stock Advisor returns as of April 2, 2018

Also, on the last page of the earnings release, you will find a reconciliation between GAAP and non-GAAP measures. With that, I would like to turn the call over to Terry.

Terrence A. Duffy -- Chairman and Chief Executive Officer

Thanks, John. As John said, we want to thank you all for joining us this morning. We appreciate your interest in CME Group. I hope you've had the chance to read through the Q1 earnings commentary document we provided earlier this morning.

As you can see, the strength of the quarter was broad-based across products and geographies as a significant number of customers actually turned to CME's markets to manage their risks. Many of the themes that we have spoken about the past few years were clearly on display this quarter. Those include our focus on driving trading volume 24 hours a day, delivering additional innovative futures and options of products to meet client needs and drive additional revenue and remaining efficient on the expense side. The combination of those efforts led to over 50% adjusted net income and diluted earnings-per-share growth in Q1.

At the end of the first quarter, we were pleased to announce the transaction with the NEX Group. We are working diligently on the timeline we outlined on the Analyst Call. The NEX shareholder vote has now been set for May 18. We have begun the process of seeking regulatory approvals.

And we continue to expect the transaction to close in the second half of this year. With that short introduction, we'd like to open the call for your questions, and we'll start now.

Questions and Answers:

Operator

Thank you. [Operator instructions] And we will take our first question from Dan Fannon of Jefferies.

Dan Fannon -- Jefferies -- Analyst

Thanks. Good morning. I guess, the first question is on market data. We saw the sequential decline and you highlighted the decline in audit fees.

I guess, a little more color on the outlook there, you had the April 1 price increase. Maybe if there's any early signs in terms of attrition, and kind of how we should be just thinking about the progression for 2018 for that line item?

Terrence A. Duffy -- Chairman and Chief Executive Officer

John?

John W. Pietrowicz -- Chief Financial Officer

Thank you, Dan. Good morning. You know, market data came in at $95 million this quarter. We had a $1 million reclass from market data to other revenue.

So including that reclass, we are running at similar levels as the first three quarters of last year. In Q4, we saw some benefits of bringing the audit function in-house with approximately $6 million of settlements. And as we mentioned previously, we expect there to be fluctuations up and down in this line quarter to quarter depending on the realization of those settlements. We've been building a pipeline that is being worked.

So we do expect those fluctuations to continue. Before I turn it over to Bryan to talk a little bit about what he is seeing in the market data business, as you indicated, the big change coming is the real-time market data price increase, which is going from $85 to $105 per screen, which went into effect in April. Real-time market data accounts for the majority of the market data revenue. And since the announcement of the price increases, we've seen a stable level of subscribers.

So Bryan?

Bryan T. Durkin -- President

I would just point out that with respect to the audits, the resolution in settlements can be quite protracted. There is a number that -- in the hopper right now that we look forward to and hope to resolve in the next quarter. You saw what happened last quarter with the amount of settlements that took place. What's even more imperative to us is the correction of behavior.

So what we are seeing is stabilization in the context of what you may have seen in past decline of screen counts. What we are seeing is an improvement in terms of the reporting of real-time screens. That, in combination with the $20 adjustment in terms of going from $85 to $105, which took effect April 1, is something that we'll be watching closely. Also, with respect to the derived data, you need to keep in mind that some of those contractual arrangements can be quite chunky themselves and can take some time to be able to negotiate those agreements.

So I would just kind of temper that a little bit in the context of quarter by quarter and how those two areas hit.

Dan Fannon -- Jefferies -- Analyst

Great. Thank you.

Terrence A. Duffy -- Chairman and Chief Executive Officer

Thanks, Dan.

Operator

And next we will go to Chris Allen with Rosenblatt.

Chris Allen -- Rosenblatt -- Analyst

Good morning, guys.

Terrence A. Duffy -- Chairman and Chief Executive Officer

Good morning, Chris.

Chris Allen -- Rosenblatt -- Analyst

I was wondering if you can give us -- I was wondering if you can give us some color on the equity and gains on unconsolidated subs assuming that's related to the S&P joint venture. I wonder if you can maybe help us think about what's been driven by the record activity we saw in the quarter and what's been driven by increased AUM to give us a sense for how should we think about the run rate moving forward?

Terrence A. Duffy -- Chairman and Chief Executive Officer

Sure. Thanks, Chris. Yeah, we've been very pleased with the performance of the S&P Dow Jones joint venture. As you know, the S&P JV revenue consists of assets under management, which is the majority of the revenue, but a significant portion is also based on derivatives trading, specifically here and in -- at CBOE.

So you've seen our performance in equities this quarter up 47%. So that is -- that gets paid through a license fee from us to them, and then we then get back 27% of it through the earnings in the JV. CBOE also has had very good activity as well. So again, it's a lot of the dynamics that are positively impacting our business is positively impacting their business.

And it's just been a tremendous business model to have and one that we're very happy to participate in.

Chris Allen -- Rosenblatt -- Analyst

Is it roughly about 80-20 AUM to activity? Is that kind of a good ballpark to think about? Or --

Terrence A. Duffy -- Chairman and Chief Executive Officer

I think it's -- they're reporting their earnings right now. So I don't have the most recent breakdown for you there, but again, like I said, it's been a positive with regard to our equity activity, really positive in terms of both the S&P. And also Nasdaq Futures has performed also very well.

Chris Allen -- Rosenblatt -- Analyst

OK. Thanks, guys.

Terrence A. Duffy -- Chairman and Chief Executive Officer

Thanks.

Operator

[Operator instructions] We will now move to Rich Repetto with Sandler O'Neill.

Richard Repetto -- Sandler O'Neill -- Analyst

Yeah, good morning, Terry. Good morning, John. I guess I'll use the question on this: I don't know whether you have an answer, but any updated views on the NEX Group acquisition and the timeline? I know you said the timeline, Terry, but the – the -- whether the mix -- how you're going to keep the dividend and how long you would extend the leverage out, I guess? Or how quickly you would pay down the debt?

John W. Pietrowicz -- Chief Financial Officer

Yeah, Rich. I'll take part of that. So there's really no new update to the timeline other than what Terry mentioned. We do expect the shareholder vote on May 18 that's been scheduled, we still plan on closing on the second half this year.

Also, as Terry mentioned, we're working through the regulatory approval process now. So no real update on the timeline. In terms of leverage and paying down the debt, really nothing more to update you on than what we put in the 2.7 announcement. And really, what we did is we approached our structure to the transaction and our approach over the next couple of years to be balanced in terms of investing in the business, returning capital to shareholders and paying down the debt.

And as you saw, we -- in the 2.7 agreement -- announcement, I should say, we expect to delever over the next couple of years down to levels that are similar to where we stand today. So that's our objective.

Richard Repetto -- Sandler O'Neill -- Analyst

OK. Thank you.

John W. Pietrowicz -- Chief Financial Officer

All right. Thanks, Rich.

Terrence A. Duffy -- Chairman and Chief Executive Officer

Thanks, Rich.

Operator

And our next question comes from Brian Bedell with Deutsche Bank.

Brian Bedell -- Deutsche Bank -- Analyst

Hi. Good morning, folks.

John W. Pietrowicz -- Chief Financial Officer

Good morning, Brian.

Brian Bedell -- Deutsche Bank -- Analyst

Maybe if I could just ask a little bit more detail on how the FX Link is going. I think you guys launched that on March 26. And I know you're very -- you're upbeat on FX Futures' volumes increasing pretty significantly over time with the uncleared margin rule. But if you could just go into a little detail about what -- how you see usage on that platform and also, while we're at it, maybe also on the new products of BTIC and TACO?

Terrence A. Duffy -- Chairman and Chief Executive Officer

Sean?

Sean Tully -- Senior Managing Director, Global Head of Financial and OTC Products

Sure. This is Sean Tully. Thank you for those great questions. So on March 26, folks, now we launched the FX Link.

We are very excited about that. We're doing several hundred contracts a day. More important thing, I'd say, in there is that we got a very good participation from the right set of clients. So this is not a couple of [Inaudible] passing around, but some clients who are using the product for the defined purpose.

With such a large innovation, I'd say, right where you're bringing together the OTC market and the futures market, it is going to take time for volumes to build and for additional participants to fully build automated trading. We're currently seeing primarily a tick point in click trading. We do expect over the coming weeks and months to see a greater number of automated traders. We know several firms that are building out, particularly end users that are building out their automated trading.

If we look at the BTIC, BTIC very exciting result this year. Last year, we averaged less than 13,000 contracts a day. This year, we're averaging more than 40,000 contracts a day. So we more than tripled the volume in BTIC.

Great innovation last year. It got nearly a $3 RPC. So very, very positive for the RPC for the entire equity complex. But I'd say great innovation.

Thanks for asking about TACO. We've got a number of new launches that are coming up over the coming month. On May 7, we're going to launch SOFR futures. On May 14, we're going to launch the TACO on the equity indices.

And then on May 21, we are launching Columbian peso, Chilean peso and CNY or the renminbi interest rate swap clearing. So we're very excited about the new product launches. In terms of TACO, TACO trade at cash open. So it is the opening market equivalent to BTIC, which is Basis Trade at Index Close.

It is not as large a market as the close. So the opening market a bit smaller, but we do expect a similar set of participants with a similar set of efficiencies delivered to them. And we are hearing a lot of excitement around it.

Brian Bedell -- Deutsche Bank -- Analyst

That's good color. And just back on FX. Just -- is that an open architecture platform? I think that's with Citi. I guess, can you do that through any banker? Or do those folks need to go to the Citi platform?

Sean Tully -- Senior Managing Director, Global Head of Financial and OTC Products

So Citi is the central prime broker, but we have now signed up several different prime brokers who are all available. So, yes, most participants now, because of the number of prime brokers that we have, will be able to access the trading. But again, it takes time for people to set up their own systems and click on the automated trading sites take advantage of it. Again, the good news is it takes a long time, right, to build up an ecosystem.

But the really good news is we've got, again, a very solid, and I'd say the right set of end customer participants who are in there doing point and click, who have said that they are in the process of building the automated trading. So it's a very good start.

Brian Bedell -- Deutsche Bank -- Analyst

Really great. Thanks for the color.

Operator

And we will now move to Christian Bolu with Bernstein.

Christian Bolu -- Bernstein -- Analyst

Good morning, Terry. Good morning, John. My question on -- curious on SOFR contract you spoke about just a minute ago. I guess, this sounds like there is significant customer appetite for the contract you'd be launching in May.

I guess, in longer term, curious how that informs your view about the kind of the long-term viability of LIBOR and LIBOR-based contracts?

John W. Pietrowicz -- Chief Financial Officer

Sure. This is John jumping in. You know, we are excited about the SOFR launch. You know, in terms of designing the contracts, we met face-to-face with more than 100 clients working with our sales team and our research team in order to design the contracts.

And the marketplace is very excited about the launch. So in recent weeks, 80% of the calls are actually in regards to SOFR or incoming from customers asking about it. So it'll also give us a big opportunity to engage with clients very closely on our interest rate products. Actually, in terms of that, CME Group is the natural home for the product.

We are always looking at delivering efficiencies to the marketplace, efficiencies to our customers because we are offering intercommodity spreads between our Fed funds futures and our Eurodollar futures, and the new SOFR futures will be the single most efficient place to execute those futures contracts in addition to that on the clearing side because we have huge hope and interest in Eurodollar futures and Fed funds futures as well as Treasury futures. You're going to see the greatest possible benefits in terms of margin and capital efficiencies. In terms of the uptick, I think that's highly uncertain. I think, there's, as we know, hundreds of trillions dollars worth of derivatives and securities in open interest in LIBOR and several trillion -- I think the last estimate from the Alternative Reference Rate Committee was on the order of 9 trillion with securities, in particular, and a very large portion of those go out in terms of maturity for many years.

So I don't personally see LIBOR going away any time soon. I think it will remain extremely healthy. And that's what we're seeing in the marketplace. But I think SOFR will be a quick, new, complementary opportunity for trading the basis or the risk between the two.

So I see SOFR as really a new opportunity for us in addition to the existing products. Another thing I'd like to mention is our Eurodollar complex continues to see recently record open interest, record volumes. So we see greater excitement in our Eurodollar futures and options than ever before. So I don't see LIBOR going away anytime soon.

Christian Bolu -- Bernstein -- Analyst

Awesome. Great output, as always. Thank you.

John W. Pietrowicz -- Chief Financial Officer

Thanks, Christian.

Operator

[Operator instructions] We will now go to Patrick O'Shaughnessy with Raymond James.

Patrick O'Shaughnessy -- Raymond James -- Analyst

Hey, good morning, guys.

John W. Pietrowicz -- Chief Financial Officer

Good morning, Patrick.

Patrick O'Shaughnessy -- Raymond James -- Analyst

I'm curious to hear your observations on the launch and the early trading of that new Shanghai crude oil contract? And to what extent you would view that to be a competitive alternative to WTI?

Derek Sammann -- Senior Managing Director, Global Head of Commodities and Options Products

Hey, Patrick. It's Derek Sammann. Yeah, we've been watching the development of that market over the last four or five years. They had some launch dates they pushed over the last three years.

We look at regional benchmarks as highly complementary to global benchmarks. The story you can hear in Inaudible] over the last couple of years is the rise of WTI as a global water-borne benchmark. And I think if you look at the results for WTI franchise over the last three years, whether it's in terms of the outpacing performance of WTI versus Brent or the now surpassed levels of WTI versus Brent, you can see that the world is demanding, and international participation has proven that to be the case. When we look at regional benchmarks, like a Chinese product launch, likely they are encouraged by the opportunity for more a broader set of domestic Chinese participants to be trading a regional benchmark.

What we are seeing and expecting is the bulk of that business that trades on that Chinese physical benchmark gets hedged out back into either Brent, WTI or more likely DME's Oman sour crude contract, which is a product launched with Dubai Mercantile Exchange which we are majority owner of. So we think the positive correlation between the regional benchmarks in the energy loan market likely provides a series of tradable regional benchmarks against the global WTI benchmark. Results year to date so far in our Asian Energy business is proving to be at record levels. Our Asian energy volume was up 43% in Q1.

So that's really pacing the developments and growth of our Energy business complex globally. Though we see it as a positive, we've seen that between DME and WTI, and we will see that contracts evolve and likely connecting this to global market over time.

Patrick O'Shaughnessy -- Raymond James -- Analyst

All right. Thanks.

Operator

And with no further questions, I'd like to turn the call back over to management for any additional or closing remarks.

Terrence A. Duffy -- Chairman and Chief Executive Officer

Well, we want to thank you all very much for joining us this morning, and we look forward to talking to you at the next quarter. Thank you very much.

Operator

[Operator signoff]

Duration: 25 minutes

Call Participants:

John Peschier -- Managing Director, Investor Relations

Terrence A. Duffy -- Chairman and Chief Executive Officer

Dan Fannon -- Jefferies -- Analyst

John W. Pietrowicz -- Chief Financial Officer

Bryan T. Durkin -- President

Chris Allen -- Rosenblatt -- Analyst

Richard Repetto -- Sandler O'Neill -- Analyst

Brian Bedell -- Deutsche Bank -- Analyst

Sean Tully -- Senior Managing Director, Global Head of Financial and OTC Products

Christian Bolu -- Bernstein -- Analyst

Patrick O'Shaughnessy -- Raymond James -- Analyst

Derek Sammann -- Senior Managing Director, Global Head of Commodities and Options Products

More CME analysis

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

10 stocks we like better than CME Group
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and CME Group wasn't one of them! That's right -- they think these 10 stocks are even better buys.

Click here to learn about these picks!

*Stock Advisor returns as of April 2, 2018